Home / Resource Library / Real-World Data Showcase Favorable Outcomes and Less Toxicity With Axi-Cel in Large B-Cell Lymphoma

Real-World Data Showcase Favorable Outcomes and Less Toxicity With Axi-Cel in Large B-Cell Lymphoma

EBMT 2021: Study compared real world results with clinical trial results of CAR T axicabtagene ciloleucel for treatment of relapsed DLBCL.